PODD Insulet margins

Relative Growth: Rel. Growth: 99

Relative Strength: Rel. Strength: 20

Relative Valuation: Rel. Valuation: 58

Relative Profitability: Rel. Profitability: 93

Gross margin

71.1%

Operating margin

16.9%

EBITDA margin

21.4%

Net margin

12.3%

For the latest period, Insulet has a gross margin of 71.1%, an operating margin of 16.9%, an EBITDA margin of 21.4%, and a net margin of 12.3%. The biggest positive change was in EBITDA margin, increasing 4.1 percentage points. The biggest negative change was in operating margin, decreasing 0.4 percentage points.

PODD margin history

Gross, operating, EBITDA and net margin trends

Insulet's margins averaged 70.15% gross, 15.81% operating, 19.45% EBITDA, and 14.34% net during the last 3 years. At present, gross, operating, and EBITDA margins are above their three-year averages, while net margin is below its three-year average.

PODD margin expansion

Year-over-year margin changes in percentage points

The largest positive change was in EBITDA margin, up 4.1 percentage points. Gross margin also expanded by 0.4 percentage points and Net margin also expanded by 2.3 percentage points, while operating margin contracted by 0.4 percentage points.

Gross margin expansion

0.4pp

Operating margin expansion

-0.4pp

EBITDA margin expansion

4.1pp

Net margin expansion

2.3pp

PODD Gross margin

Over the last 3 years, Insulet's gross margin averaged 70.15%. At present, Insulet's current gross margin is 71.1%, which is 1 percentage points above its three-year average. During this period, gross margin reached a high of 71.6% in Dec 2025 and a low of 68.3% in Dec 2023.

PODD Operating margin

Throughout the last 3 years, Insulet had an average operating margin of 15.81%. Against its three-year average, Insulet's operating margin is currently 16.9%, 1.1 percentage points above its three-year average. Looking back over the last 3 years, Insulet's operating margin reached 17.5% at its highest point in Mar 2026 and 13% at its lowest in Dec 2023.

PODD EBITDA margin

Insulet's EBITDA margin averaged 19.45% over the last 3 years. Compared with its three-year average, Insulet's current EBITDA margin is 21.4% and is 2 percentage points above its three-year average. Over the last 3 years, Insulet's EBITDA margin peaked at 21.4% in Jun 2026 and reached a low of 17.3% in Jun 2025.

PODD Net margin

Over the last 3 years, Insulet's net margin averaged 14.34%. Currently, Insulet's current net margin is 12.3%, which is 2 percentage points below its three-year average. During this period, net margin reached a high of 21.2% in Sep 2024 and a low of 9.1% in Dec 2025.

PODD margin group comparison

Margins compared with peer-group, industry and sector averages

With a gross margin of 71.1%, PODD is above the Healthcare sector, the industry and its peers average. But compared to its Healthcare sector average of 68.3%, Insulet's gross margin is only 4.1% higher.

PODD margin peer comparison

Compare margins with selected peers

Frequently asked questions

What is Insulet's gross margin?

As of Jun 30, 2026, PODD has a gross margin of 71.1%.

What is Insulet's operating margin?

As of Jun 30, 2026, PODD has an operating margin of 16.9%.

What is Insulet's EBITDA margin?

The current EBITDA margin for PODD is 21.4% as of Jun 30, 2026.

What is Insulet's net margin?

The current net margin for PODD is 12.3% as of Jun 30, 2026.

What are the average margins of PODD?

Insulet's gross, operating, EBITDA, and net margins averaged 70.2% gross, 15.8% operating, 19.5% EBITDA, and 14.3% net over the last 3 years.

What are the highest historical margins of PODD?

Insulet's highest recorded margins during the past 5 years were 71.6% gross in Dec 2025, 17.5% operating in Mar 2026, 21.4% EBITDA in Jun 2026, and 21.2% net in Sep 2024.

What are the lowest historical margins of PODD?

Looking back across 5 years, PODD reached its lowest margins at 61.1% gross in Mar 2023, 2% operating in Mar 2023, 7.7% EBITDA in Mar 2023, and 0% net in Mar 2023.